New Research Explores the Relationship Between Statins and Glaucoma
People taking cholesterol-lowering medication may be interested to learn that these drugs could have benefits beyond cardiovascular health. New research suggests that statin use may also be associated with a lower likelihood of developing glaucoma and needing certain eye treatments.
A study from the University of California San Diego School of Medicine found that people taking statins had a 15% lower risk of developing open-angle glaucoma compared with those who did not use these medications.
The research also identified lower rates of glaucoma surgery, laser procedures, and pressure-lowering eye drop use among statin users who already had glaucoma.
Although these findings are encouraging, researchers emphasize that the results demonstrate an association rather than proof that statins prevent glaucoma.
What Did the Statin and Glaucoma Study Find?
The research was published online in the British Journal of Ophthalmology and reported by NZ Optics on November 5, 2026.
Researchers from the University of California San Diego School of Medicine conducted a retrospective cohort study examining the relationship between statin use and glaucoma development and treatment.
The findings identified several differences between people taking statins and those who were not using these medications.
- 15% lower risk: Statin use was associated with a lower risk of developing open-angle glaucoma.
- 36% lower risk: At five years, statin users had a lower risk of undergoing incisional glaucoma surgery.
- 55% lower risk: Statin use was associated with a reduced likelihood of undergoing minimally invasive glaucoma surgery (MIGS).
- 60% lower risk: Researchers identified a lower likelihood of undergoing selective laser trabeculoplasty (SLT).
- 12% lower likelihood: Statin users were less likely to require pressure-lowering eye drops.
These findings suggest that statin use may be associated with differences in both glaucoma development and the need for subsequent treatment.
Understanding How Statins May Affect Eye Health
Statins are medications commonly prescribed to lower cholesterol levels and reduce the risk of cardiovascular complications. They work by inhibiting an enzyme involved in cholesterol production in the liver.
However, researchers have also become interested in the possible effects of statins beyond cholesterol management, particularly their potential relationship with inflammation, blood circulation, and nerve protection.
These properties have raised questions about whether statins could influence conditions involving damage to sensitive nerve tissues, including glaucoma.
What Is the Possible Neuroprotective Effect?
Neuroprotection refers to processes that help preserve nerve cells and reduce damage to the nervous system.
Glaucoma is particularly relevant to this area of research because it involves progressive damage to retinal ganglion cells and their nerve fibers, which form the optic nerve.
These cells transmit visual information from the retina to the brain. When they become damaged, patients can experience gradual and permanent vision loss.
Researchers are investigating whether certain properties associated with statins could help protect these nerve structures. However, the latest observational findings do not establish the biological mechanism responsible for the reported association.
Why Open-Angle Glaucoma Is a Major Eye Health Concern
Open-angle glaucoma is one of the most common forms of glaucoma. It develops when damage occurs to the optic nerve, often in association with elevated intraocular pressure.
The condition usually progresses gradually, and people may not recognize that their vision is changing during its early stages.
Unlike some eye conditions that produce immediate discomfort, open-angle glaucoma can develop without noticeable pain or obvious warning signs.
How Increased Eye Pressure Can Damage the Optic Nerve
The eye continuously produces a clear fluid called aqueous humor. This fluid circulates through the front portion of the eye and normally drains through a structure known as the trabecular meshwork.
If drainage becomes less efficient, pressure inside the eye may increase. In susceptible individuals, prolonged pressure-related stress can contribute to optic nerve damage.
However, glaucoma can also develop in people whose measured eye pressure remains within the statistically normal range. This is why evaluating the optic nerve and visual function is important rather than relying on pressure measurements alone.
Understanding the Glaucoma Treatments Examined in the Research
One interesting aspect of the study was its examination of different glaucoma treatments, rather than focusing exclusively on new diagnoses.
Researchers considered three important treatment approaches: incisional surgery, minimally invasive glaucoma surgery, and selective laser trabeculoplasty.
Incisional Glaucoma Surgery
Traditional incisional glaucoma procedures involve creating a new pathway or modifying existing drainage structures to help lower intraocular pressure.
These procedures may be considered when medication or other approaches do not provide sufficient pressure control.
The study found that statin use was associated with a 36% lower risk of undergoing this type of surgery at five years.
Minimally Invasive Glaucoma Surgery
Minimally invasive glaucoma surgery, commonly called MIGS, includes procedures designed to improve fluid drainage using smaller surgical approaches.
These techniques are generally intended to reduce intraocular pressure while minimizing surgical disruption compared with some traditional procedures.
At five years, statin use was associated with a 55% lower risk of undergoing MIGS in the research.
Selective Laser Trabeculoplasty
Selective laser trabeculoplasty, or SLT, is a treatment that uses controlled laser energy on the trabecular meshwork to improve aqueous humor drainage.
It is commonly used for patients with open-angle glaucoma or elevated eye pressure when laser treatment is considered appropriate.
The research reported a 60% lower risk of undergoing SLT among statin users.
Pressure-Lowering Eye Drops
Eye drops are frequently used to manage glaucoma by reducing aqueous humor production or improving its drainage.
The study also found a 12% lower likelihood of using pressure-lowering eye drops among statin users.
These treatment findings are associations and should not be interpreted as evidence that statins can replace established glaucoma therapies.
What Did Researchers Find After 10 Years?
The investigation also examined longer-term outcomes over a 10-year period.
Researchers reported that statin use continued to be associated with lower risks of incisional glaucoma surgery, MIGS, selective laser trabeculoplasty, and pressure-lowering eye drop use.
However, the NZ Optics report did not provide separate numerical percentages for these 10-year findings. Therefore, the five-year estimates should not be applied to the 10-year period.
The longer observation period provides another reason to investigate the potential relationship between statins and glaucoma through more detailed clinical research.
Important Limitations of the Statin Research
Despite the encouraging findings, the researchers identified important limitations that readers should understand.
The investigation used a retrospective observational design. This means researchers analyzed existing medical information rather than randomly assigning participants to receive statins or an alternative treatment.
As a result, the study cannot establish that statins directly caused the lower glaucoma risk or reduced need for treatment.
People taking statins may differ from non-users in other ways, including their medical history, healthcare access, cardiovascular risk factors, and other treatments.
The researchers also lacked access to individual patient information, including intraocular pressure measurements and detailed surgical records.
These limitations make it difficult to determine precisely why the observed differences occurred.
Why Randomized Clinical Trials Are Needed
Senior study author Dr Robert Weinreb, a distinguished professor in the Viterbi Family Department of Ophthalmology at UC San Diego School of Medicine and an ophthalmologist at UC San Diego Health, highlighted the contribution of the findings to research into the potential neuroprotective properties of statins.
However, the research team emphasized the need for prospective randomized clinical trials to better establish whether statin use influences glaucoma development and treatment outcomes.
Such trials could help determine whether the observed associations represent a genuine protective effect and which patient groups, if any, might benefit.
How Glaucoma Can Be Detected Through Eye Examinations
Regardless of whether someone takes statins, regular comprehensive eye examinations remain important for detecting glaucoma early.
Eye care professionals use several tests to evaluate pressure, drainage structures, and optic nerve health.
- Tonometry: Measures intraocular pressure to identify elevated readings.
- Optical coherence tomography (OCT): Produces detailed images of retinal structures and nerve fiber layers.
- Visual field testing: Checks for areas of reduced peripheral vision.
- Gonioscopy: Examines the drainage angle to help determine the type of glaucoma.
- Dilated optic nerve examination: Allows the eye care professional to assess the appearance of the optic nerve.
These examinations provide complementary information and help identify changes that may otherwise go unnoticed.
When Should You See an Eye Doctor?
People with a family history of glaucoma, elevated intraocular pressure, diabetes, or previous optic nerve abnormalities should discuss an appropriate examination schedule with an eye care professional.
Arrange an eye examination if you notice persistent blurred vision, changes in peripheral vision, or unexplained visual disturbances.
Sudden severe eye pain, redness, blurred vision, halos around lights, headache, or nausea require urgent medical assessment because these symptoms can indicate acute angle-closure glaucoma or another serious eye condition.
If you are already taking statins for cholesterol management, do not change or discontinue your medication because of this research. Statins should be prescribed according to your individual cardiovascular health needs, not as an established glaucoma prevention treatment.
Frequently Asked Questions
1. Can statins prevent glaucoma?
Current research suggests that statin use may be associated with a lower risk of developing open-angle glaucoma. However, the available observational evidence does not establish that statins prevent the disease.
2. How much lower was the glaucoma risk among statin users?
The study reported a 15% lower risk of developing open-angle glaucoma among statin users. It also identified lower risks of several glaucoma treatments, including incisional surgery, MIGS, and SLT at five years.
3. Should people take statins to protect their eyesight?
No. Statins are prescribed primarily for cholesterol management and cardiovascular risk reduction. Their potential protective effects against glaucoma remain under investigation, and they should not be started specifically for glaucoma prevention.
What This Research Means for the Future of Glaucoma Prevention
The findings from the University of California San Diego School of Medicine provide another interesting direction for glaucoma research. The association between statin use, lower glaucoma incidence, and reduced treatment requirements deserves further investigation.
Nevertheless, observational research cannot establish a direct protective effect, and the missing patient-level information limits the conclusions that can be drawn.
Future randomized clinical trials will be important in determining whether statins could eventually have a role beyond their established cardiovascular applications.
For now, people concerned about glaucoma should prioritize regular comprehensive eye examinations, follow their prescribed treatment plans, and discuss individual risk factors with an ophthalmologist or optometrist.
